# Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

> **NCT01634217** · PHASE1 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 16 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Acute Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Myelodysplastic Syndrome

## Interventions

- **BIOLOGICAL:** iTreg

## Key facts

- **NCT ID:** NCT01634217
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-08
- **Primary completion:** 2017-12-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01634217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01634217, "Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01634217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*